CatalystPit

AKBAAkebia Therapeutics, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $0.92 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$254.94M
RECENT INSIDER TRADES
  • 2026-08-10 · Butler John P. (CEO and President) · OTHER
  • 2026-07-01 · Ostrowski Erik (SVP, CFO, CBO & Treasurer) · SELL
  • 2026-03-05 · Butler John P. (CEO and President) · BUY
  • 2026-02-04 · Ostrowski Erik (SVP, CFO, CBO & Treasurer) · SELL
  • 2026-02-04 · Malabre Richard C (SVP, Chief Accounting Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders183
Shares held142,301,155
Value$168.00M
Percent of shares outstanding51.35%
As of quarter end2026-06-30
RECENT NEWS
  • Akebia to conduct investor meetings at U.S. Bancorp BTIG Kidney Health Forum
  • Akebia Therapeutics grants stock options to newly-hired employee
  • Akebia Therapeutics doses first patient in Phase 2 trial of ebribafusp
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Akebia Therapeutics, Inc. (AKBA) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit